drugset / Trial / NCT02747511

IV Haloperidol for the Treatment of Headache in the ED

NCT02747511

Phase 4 Completed 118 enrolled Western Michigan University School of Medicine
RandomizedParallel-groupDouble-blindTreatment

Summary

Single center, double-blind, randomized, placebo-controlled trial evaluating analog pain scores in patients who present to the emergency department (ED) with a complaint of headache. A total of 150 patients age 13-55 presenting to the emergency department with headache will be enrolled from October 2015 - October 2016. Patients will be randomized and pain scores and side effects will be recorded at 0, 30, 60, and 90 minutes. Follow-up will be performed by telephone at 24 hours.

Timeline

Start
2015-10
Primary completion
2017-10
Completion
2017-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Haloperidol Other / unclassified 2.5 mg Intravenous

Indications